[25-NSE] Affimed N.V. SEC Filing
Nasdaq Stock Market LLC has filed Form 25 to strike Affimed N.V. (AFMD) common stock from listing and registration under Section 12(b) of the Exchange Act. The notification, signed on 2025-07-21 by a Nasdaq hearings advisor, states that the exchange believes it meets all regulatory requirements for delisting. No financial results, trading data, or rationale are provided in the filing.
The action will remove AFMD from the Nasdaq Global Market once the SEC’s 10-day period elapses, and registration under Section 12(g) will be terminated after 90 days unless the company files contrary documentation. Investors should anticipate the stock moving to an over-the-counter venue or another exchange, subject to separate listing standards.
- None.
- Nasdaq filed Form 25 to delist AFMD common stock, removing exchange listing and SEC Section 12(b) registration, which typically reduces liquidity and investor access.
Insights
TL;DR: Nasdaq is delisting AFMD; liquidity and visibility will drop, raising risk.
The Form 25 signals a formal removal of Affimed’s common shares from Nasdaq. Delistings typically erode trading volume, widen bid-ask spreads, and restrict institutional ownership because many funds cannot hold OTC securities. While the form does not disclose why Nasdaq acted, the absence of financial or compliance details limits clarity. In my view, the event is materially negative for existing shareholders and may pressure the share price as index funds and mandate-bound investors exit positions.